Can Fresh INTEREST Breathe New Life Into Faron's Traumakine?

 
• By Kevin Grogan

Faron's ARDS drug looked doomed after the INTEREST study earlier this year but the Finnish group claims that a DNA analysis has identified some patients for whom Traumakine treatment could potentially be effective.

Diver
Faron dives deep for positive data • Source: Shutterstock

More from Respiratory

More from Therapy Areas